Comparing two anti-nausea medicines in the ER
Treatments studied
Part of Digestive system clinical trials.
This trial compares two anti-nausea medicines (fosaprepitant and metoclopramide) given in the emergency room to see which works better for adults with nausea or vomiting. If you qualify, you would receive one of the study medications and have follow-up calls to check how you're feeling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the emergency room because of nausea or vomiting.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You have not taken any anti-nausea medicine or received IV fluids before coming to the ER today.
- You do not have a slow heart rate (below 60 beats per minute) or a heart rhythm problem (prolonged QTc).
- You can speak English or Spanish, have a phone for follow-up, and do not have confusion or dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a drug called fosaprepitant can help people in the emergency room whose nausea and vomiting don't improve with standard medicine. It may be an option if you still feel sick 2 hours after your first nausea treatment.
This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.
This trial tests whether metoclopramide, promethazine, or prochlorperazine works best to reduce nausea and symptoms during a new episode of vertigo. It may help you find the most effective medicine for acute peripheral vertigo with nausea or vomiting.
This Phase 3 trial tests whether ondansetron (a medicine used to reduce nausea and vomiting) works better than a placebo, along with usual care, for adults with acute gastroenteritis. It also checks how safe ondansetron is in this setting, especially for the heart rhythm and other side effects.
This study tests two different medication combinations to prevent nausea and vomiting after laparoscopic gallbladder removal surgery. You'll receive either ondansetron plus metoclopramide, or dexamethasone plus metoclopramide, and researchers will track how quickly you need rescue medication if nausea occurs.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
Hear when a new Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.